A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer

One of the major goals of precision oncology is to promote combination therapy to improve efficacy and reduce side effects of anti-cancer drugs based on their molecular mechanisms. In this study, we aimed to develop and validate new nanoformulations of docetaxel (DTX) and bortezomib (BTZ) for target...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Pharmacol Sin
Main Authors: Wang, Xin-shuai, Kong, De-jiu, Lin, Tzu-yin, Li, Xiao-cen, Izumiya, Yoshihiro, Ding, Xue-zhen, Zhang, Li, Hu, Xiao-chen, Yang, Jun-qiang, Gao, She-gan, Lam, Kit S, Li, Yuan-pei
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520194/
https://ncbi.nlm.nih.gov/pubmed/28552907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.43
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados